Emerging research once again appears to demonstrate that cannabis — specifically cannabidiol (CBD) and other non-psychoactive cannabinoids — might be an effective means to destroy cancer cells. Newsweek summarized the recent paper published in the journal, Anticancer Research, “Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules”. From Newsweek.com:
Though THC is the main cannabinoid associated with marijuana and has been recognized to have a “really strong anti-cancer effect,” Liu says, “it’s not a good candidate for therapeutic use because of its psychoactive properties.”
He examined whether several lesser-known cannabinoids would impact the growth of leukemia cells both individually and in combination.
“They’re good at killing cancer cells,” he says. And “because they’re not psychoactive, you can actually have the benefits associated with anti-cancer technology but not have the feelings of high, which are associated with THC.”
Some cannabinoids are better at killing cancer cells and others are better at slowing their growth, so combining certain cannabinoids has a heightened effect. “It’s like a double hit,” he says.
Read the full article on Newsweek.com or the paper’s abstract from the International Journal of Cancer Research and Treatment.
This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.